Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017

• Pubblicazione: Washington : , : U.S. Government Publishing Office, , 2017
• Descrizione fisica: 1 online resource (iii, 54 pages)
• Soggetto topico: Pharmaceutical industry - Corrupt practices - United States; Pharmaceutical policy - United States; Generic drugs - Development - United States; Prescription pricing - United States; Competition - United States; Consumer protection - United States
• Soggetto genere / forma: Legislative hearings.
• Note generali: "Serial no. 115-33."; Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
• Nota di bibliografia: Includes bibliographical references.
• Altri titoli varianti: Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain
• Titolo autorizzato: Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910706553103321
• Lo trovi qui: Univ. Federico II